Trials / Unknown
UnknownNCT02933164
A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Senseonics, Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical investigation is to evaluate the effectiveness of modified Sensor designs on the longevity (up to 180 days) of the Senseonics Continuous Glucose Monitoring (CGM) System. The investigation will also evaluate safety of the Senseonics CGM System usage, while in the clinic and during home use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous Glucose Monitoring System | Effectiveness and safety of a Continuous Glucose Monitoring System |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-08-01
- First posted
- 2016-10-14
- Last updated
- 2017-05-22
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02933164. Inclusion in this directory is not an endorsement.